These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 27481515)

  • 1. PKC iota promotes cellular proliferation by accelerated G1/S transition via interaction with CDK7 in esophageal squamous cell carcinoma.
    Ni S; Chen L; Li M; Zhao W; Shan X; Wu M; Cheng J; Liang L; Wang Y; Jiang W; Zhang J; Ni R
    Tumour Biol; 2016 Oct; 37(10):13799-13809. PubMed ID: 27481515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
    He Z; Yi J; Jin L; Pan B; Chen L; Song H
    Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical protein kinase Cι (PKCι) promotes metastasis of esophageal squamous cell carcinoma by enhancing resistance to Anoikis via PKCι-SKP2-AKT pathway.
    Liu SG; Wang BS; Jiang YY; Zhang TT; Shi ZZ; Yang Y; Yang YL; Wang XC; Lin DC; Zhang Y; Yang H; Cai Y; Zhan QM; Wang MR
    Mol Cancer Res; 2011 Apr; 9(4):390-402. PubMed ID: 21310827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGFBI Expression in Cancer Stromal Cells is Associated with Poor Prognosis and Hematogenous Recurrence in Esophageal Squamous Cell Carcinoma.
    Ozawa D; Yokobori T; Sohda M; Sakai M; Hara K; Honjo H; Kato H; Miyazaki T; Kuwano H
    Ann Surg Oncol; 2016 Jan; 23(1):282-9. PubMed ID: 25448803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. XB130 as an independent prognostic factor in human esophageal squamous cell carcinoma.
    Shiozaki A; Kosuga T; Ichikawa D; Komatsu S; Fujiwara H; Okamoto K; Iitaka D; Nakashima S; Shimizu H; Ishimoto T; Kitagawa M; Nakou Y; Kishimoto M; Liu M; Otsuji E
    Ann Surg Oncol; 2013 Sep; 20(9):3140-50. PubMed ID: 22805860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sam68 promotes cellular proliferation and predicts poor prognosis in esophageal squamous cell carcinoma.
    Wang Y; Liang L; Zhang J; Li M; Zhu J; Gong C; Yang L; Zhu J; Chen L; Ni R
    Tumour Biol; 2015 Nov; 36(11):8735-45. PubMed ID: 26050229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EpCAM, a potential therapeutic target for esophageal squamous cell carcinoma.
    Matsuda T; Takeuchi H; Matsuda S; Hiraiwa K; Miyasho T; Okamoto M; Kawasako K; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S356-64. PubMed ID: 24566863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Expression of BCCIP β Can Promote Proliferation of Esophageal Squamous Cell Carcinoma.
    Chen L; Ni S; Li M; Shen C; Lin Z; Ouyang Y; Xia F; Liang L; Jiang W; Ni R; Zhang J
    Dig Dis Sci; 2017 Feb; 62(2):387-395. PubMed ID: 27995408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-106b promotes migration and invasion through enhancing EMT via downregulation of Smad 7 in Kazakh's esophageal squamous cell carcinoma.
    Dai F; Liu T; Zheng S; Liu Q; Yang C; Zhou J; Chen Y; Sheyhidin I; Lu X
    Tumour Biol; 2016 Nov; 37(11):14595-14604. PubMed ID: 27619676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PITX2: a promising predictive biomarker of patients' prognosis and chemoradioresistance in esophageal squamous cell carcinoma.
    Zhang JX; Tong ZT; Yang L; Wang F; Chai HP; Zhang F; Xie MR; Zhang AL; Wu LM; Hong H; Yin L; Wang H; Wang HY; Zhao Y
    Int J Cancer; 2013 Jun; 132(11):2567-77. PubMed ID: 23132660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly (C)-binding protein 2 (PCBP2) promotes the progression of esophageal squamous cell carcinoma (ESCC) through regulating cellular proliferation and apoptosis.
    Ye J; Zhou G; Zhang Z; Sun L; He X; Zhou J
    Pathol Res Pract; 2016 Aug; 212(8):717-25. PubMed ID: 27461833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-498 in esophageal squamous cell carcinoma: clinicopathological impacts and functional interactions.
    Islam F; Gopalan V; Law S; Tang JC; Chan KW; Lam AK
    Hum Pathol; 2017 Apr; 62():141-151. PubMed ID: 28188753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequestosome 1 protects esophageal squamous carcinoma cells from apoptosis via stabilizing SKP2 under serum starvation condition.
    Shi C; Pan BQ; Shi F; Xie ZH; Jiang YY; Shang L; Zhang Y; Xu X; Cai Y; Hao JJ; Wang MR
    Oncogene; 2018 Jun; 37(24):3260-3274. PubMed ID: 29551772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of sex-determining region Y-box 9 (SOX9) promotes cell proliferation and tumorigenicity in esophageal squamous cell carcinoma.
    Hong Y; Chen W; Du X; Ning H; Chen H; Shi R; Lin S; Xu R; Zhu J; Wu S; Zhou H
    Oncotarget; 2015 Oct; 6(31):31241-54. PubMed ID: 26384302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD10 expression is enhanced by Twist1 and associated with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro and in vivo.
    Lee KW; Sung CO; Kim JH; Kang M; Yoo HY; Kim HH; Um SH; Kim SH
    Int J Cancer; 2015 Jan; 136(2):310-21. PubMed ID: 24895167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutually exclusive mutations in NOTCH1 and PIK3CA associated with clinical prognosis and chemotherapy responses of esophageal squamous cell carcinoma in China.
    Song B; Cui H; Li Y; Cheng C; Yang B; Wang F; Kong P; Li H; Zhang L; Jia Z; Bi Y; Wang J; Zhou Y; Liu J; Wang J; Zhao Z; Zhang Y; Hu X; Shi R; Yang J; Liu H; Yan T; Li Y; Xu E; Qian Y; Xi Y; Guo S; Chen Y; Wang J; Li G; Liang J; Jia J; Chen X; Guo J; Wang T; Zhang Y; Li Q; Wang C; Cheng X; Zhan Q; Cui Y
    Oncotarget; 2016 Jan; 7(3):3599-613. PubMed ID: 26528858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition.
    Lee KW; Kim JH; Han S; Sung CO; Do IG; Ko YH; Um SH; Kim SH
    Ann Surg Oncol; 2012 Jan; 19(1):326-35. PubMed ID: 21732143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis.
    Ji YM; Zhou XF; Zhang J; Zheng X; Li SB; Wei ZQ; Liu T; Cheng DL; Liu P; Song K; Tan T; Zhu H; Guo JL
    Oncotarget; 2016 Mar; 7(12):14188-98. PubMed ID: 26893358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-214 inhibits invasion and migration via downregulating GALNT7 in esophageal squamous cell cancer.
    Lu Q; Xu L; Li C; Yuan Y; Huang S; Chen H
    Tumour Biol; 2016 Nov; 37(11):14605-14614. PubMed ID: 27619677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.